Biolytica logo

Biolytica

Increasing human healthspan and performance through state-of-the-art health data analytics.

5 employees · est. 2021 · Zug, Switzerland

VS
Loyal / Cellular Longevity logo

Loyal / Cellular Longevity

Loyal is developing the first-ever drugs intended to extend the healthspan and lifespan of dogs.

53 employees · est. 2019 · San Francisco, United States

Loyal / Cellular Longevity is the older company (2021 vs 2019); Loyal / Cellular Longevity is the larger of the two.

Side-by-Side Comparison

Biolytica Loyal / Cellular Longevity
Founded
2021 2019 older
Headquarters
Zug, Switzerland San Francisco, United States
Employees
5 53 larger
Industry
Digital Health, Health Care, Health and Wellness Biotechnology
Funding Stage
Seed Series B
Total Funding
$5.25M $115.00M
Funding Rounds
1 6
Services
Not tracked yet Development of longevity drugs for dogs, Preventive care solutions for canine health, Conducting clinical trials for veterinary pharmaceuticals, Partnerships with pharmaceutical companies for drug development
Target Customers
Not tracked yet Veterinarians, Dog owners, Pet healthcare professionals
Taxonomy
Health Data Analytics, Human Healthspan, Performance, Longevity Programs, Personalized, Scientific Breakthroughs, Medical Breakthroughs, Healthcare Innovation Healthspan, Longevity, Aging Process, Age-related Diseases, Cancer Prevention, Dementia Prevention, Drug Development, Animal Health, Life Extension
Website
biolytica.com loyalfordogs.com
Biolytica logo

About Biolytica

Biolytica is a health tech startup founded in 2021 in Switzerland. With a mission to increase human healthspan and performance, the company utilizes state-of-the-art health data analytics and personalized longevity programs based on the latest scientific and medical breakthroughs. Their slogan, "Inc...

Loyal / Cellular Longevity logo

About Loyal / Cellular Longevity

Loyal, operating under the umbrella of Cellular Longevity, is a promising player in the biotechnology industry, founded in 2019 and headquartered in the United States. The company is pioneering the development of drugs aimed explicitly at extending the healthspan and lifespan of dogs, with future pl...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Biolytica and Loyal / Cellular Longevity — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Biolytica and Loyal / Cellular Longe... — by email.

Frequently Asked Questions

Biolytica — Increasing human healthspan and performance through state-of-the-art health data analytics.. Loyal / Cellular Longevity — Loyal is developing the first-ever drugs intended to extend the healthspan and lifespan of dogs.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Biolytica has raised $5.25M while Loyal / Cellular Longevity has raised $115.00M.
Biolytica and Loyal / Cellular Longevity operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Biolytica with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy